🇺🇸 FDA
Patent

US 7858657

Wortmannin analogs and methods of using same in combination with chemotherapeutic agents

granted A61KA61K31/337A61K31/35

Quick answer

US patent 7858657 (Wortmannin analogs and methods of using same in combination with chemotherapeutic agents) held by Arizona Board of Regents, Acting on Behalf of the University of Arizona expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents, Acting on Behalf of the University of Arizona
Grant date
Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/337, A61K31/35, A61K31/366, A61K31/40